The DOI matches its Crossref record; 43 of the 44 references it cites were found in a registry or an index.
A census of human cancer genes
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Focusing on cancer census genes [28], we observed such complex expression patterns for 26 of the current 513 cancer census genes (Additional file 1: Table S2).”
From Comparison of RNA-seq and microarray-based models for clinical endpoint prediction (2015) · cites this paper as [28]
In the citing paper
“We noted that many of the boundaries of cancer driver genes were altered in specific histological subtypes (Fig. 3a, Supplementary Table 2).”
From Disruption of chromatin folding domains by somatic genomic rearrangements in human cancer (2020) · cites this paper as [29]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Pfam Protein Families Database
Bateman, A. G. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.1.276 · Cited by 14,075
Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S. I., Puc, J., Miliaresis, C., Rodgers, L., McCombie, R., et al. (1997) · Science · doi:10.1126/science.275.5308.1943 · Cited by 4,785
Gain-of-Function Mutations of c- kit in Human Gastrointestinal Stromal Tumors
Hirota, S., Isozaki, K., Moriyama, Y., Hashimoto, K., Nishida, T., Ishiguro, S., Kawano, K., Hanada, M., Kurata, A., Takeda, M., et al. (1998) · Science · doi:10.1126/science.279.5350.577 · Cited by 4,487
The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer
Fishel, R. A., Lescoe, M. K., Rao, M. R. S., Copeland, N. G., Jenkins, N. A., Garber, J. E., Kane, M., & Kolodner, R. D. (1993) · Cell · doi:10.1016/0092-8674(93)90546-3 · Cited by 2,884
A Single Ataxia Telangiectasia Gene with a Product Similar to PI-3 Kinase
Savitsky, K., Bar-Shira, A., Gilad, S., Rotman, G., Ziv, Y., Vanagaite, L., Tagle, D. A., Smith, S., Uziel, T., Sfez, S., et al. (1995) · Science · doi:10.1126/science.7792600 · Cited by 2,785
A cell cycle regulator potentially involved in genesis of many tumor types
Kamb, A., Gruis, N. A., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S. V., Stockert, E., Day, R. S., Johnson, B. E., & Skolnick, M. H. (1994) · Science · doi:10.1126/science.8153634 · Cited by 2,751
PDGFRA Activating Mutations in Gastrointestinal Stromal Tumors
Heinrich, M. C., Corless, C. L., Duensing, A. U., McGreevey, L. S., Chen, C.-J., Joseph, N. E., Singer, S., Griffith, D., Haley, A., Town, A., et al. (2003) · Science · doi:10.1126/science.1079666 · Cited by 2,297
Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer
Leach, F. S., Nicolaides, N. C., Papadopoulos, N., Liu, B., Jen, J., Parsons, R. E., Peltomäki, P., Sistonen, P., Aaltonen, L. A., Nyström, M., et al. (1993) · Cell · doi:10.1016/0092-8674(93)90330-s · Cited by 2,271
Merlo, A., Herman, J. G., Mao, L., Lee, D. J., Gabrielson, E. W., Burger, P. C., Baylin, S. B., & Sidransky, D. (1995) · Nature Medicine · doi:10.1038/nm0795-686 · Cited by 1,992
A serine/threonine kinase gene defective in Peutz–Jeghers syndrome
Hemminki, A., Markie, D., Tomlinson, I. P. M., Avizienyte, E., Roth, S., Loukola, A., Bignell, G. R., Warren, W., Aminoff, M., Höglund, P., et al. (1998) · Nature · doi:10.1038/34432 · Cited by 1,680
Self-citation
Cited by
Sorted by citations
Items 901–1,000 of 1,007
OncoScore: a novel, Internet-based tool to assess the oncogenic potential of genes
Piazza, R., Ramazzotti, D., Spinelli, R., Pirola, A., Sano, L. D., Ferrari, P., Magistroni, V., Cordani, N., Sharma, N. D., & Gambacorti-Passerini, C. B. (2017) · Scientific Reports · doi:10.1038/srep46290 · Cited by 56
Damodaran, S., Miya, J., Kautto, E. A., Zhu, E. Y., Samorodnitsky, E., Datta, J., Reeser, J. W., & Roychowdhury, S. (2015) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2015.05.002 · Cited by 54
Yu, M., Zloty, D. M., Cowan, B. J., Shapiro, J., Haegert, A. M., Bell, R. H., Warshawski, L., Carr, N. J., & McElwee, K. J. (2008) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5701243 · Cited by 55
Zhou, S.-F., He, S., Zeng, S., Zhou, Z.-W., & He, Z. (2015) · Drug Design Development and Therapy · doi:10.2147/dddt.s73551 · Cited by 56
Kilpinen, S. K., Ojala, K., & Kallioniemi, O. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015068 · Cited by 54
The Landscape of Candidate Driver Genes Differs between Male and Female Breast Cancer
Johansson, I., Ringnér, M., & Hedenfalk, I. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078299 · Cited by 54
Dong, C., Guo, Y., Yang, H., He, Z., Liu, X., & Wang, K. (2016) · Genome Medicine · doi:10.1186/s13073-016-0390-0 · Cited by 55
Pellacani, D., Tan, S., Lefort, S., & Eaves, C. J. (2019) · The EMBO Journal · doi:10.15252/embj.2018100330 · Cited by 55
Understanding oncogenicity of cancer driver genes and mutations in the cancer genomics era
Porta‐Pardo, E., Valencia, A., & Godzik, A. (2020) · FEBS Letters · doi:10.1002/1873-3468.13781 · Cited by 57
Showpnil, I. A., Selich‐Anderson, J., Taslim, C., Boone, M. A., Crow, J. C., Theisen, E. R., & Lessnick, S. L. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac747 · Cited by 59
Depreeuw, J., Hermans, E., Schrauwen, S., Annibali, D., Coenegrachts, L., Thomas, D., Luyckx, M., Gutierrez-Roelens, I., Debruyne, D., Konings, K., et al. (2015) · Gynecologic Oncology · doi:10.1016/j.ygyno.2015.07.104 · Cited by 53
The new pig on the block: modelling cancer in pigs
Flisikowska, T., Kind, A., & Schnieke, A. (2013) · Transgenic Research · doi:10.1007/s11248-013-9720-9 · Cited by 53
Amplified Genes May Be Overexpressed, Unchanged, or Downregulated in Cervical Cancer Cell Lines
Vázquez-Mena, Ó., Medina‐Martínez, I., Juárez-Torres, E., Barrón-Palma, E. V., Espinosa-García, A. M., Villegas‐Sepúlveda, N., Gómez-Laguna, L., Nieto-Martínez, K., Orozco, L., Román-Basaure, E., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032667 · Cited by 55
Large scale chromosomal mapping of human microRNA structural clusters
Mathelier, A., & Carbone, A. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt112 · Cited by 53
Kinome expression profiling and prognosis of basal breast cancers
Sabatier, R., Finetti, P., Mamessier, É., Raynaud, S., Cervera, N., Lambaudie, É., Jacquemier, J. D., Viens, P., Birnbaum, D., & Bertucci, F. (2011) · Molecular Cancer · doi:10.1186/1476-4598-10-86 · Cited by 53
Brady, S. W., Zhang, J., Tsai, M.-H., & Yu, D. (2015) · Cancer Biology & Therapy · doi:10.1080/15384047.2014.1002693 · Cited by 54
Genetic Progression of High Grade Prostatic Intraepithelial Neoplasia to Prostate Cancer
Jung, S., Shin, S. Y., Kim, M. S., Baek, I.-P., Lee, J. Y., Lee, S. H., Kim, T., Lee, S. H., & Chung, Y. (2015) · European Urology · doi:10.1016/j.eururo.2015.10.031 · Cited by 53
Levings, D. C., Wang, X., Kohlhase, D., Bell, D. A., & Slattery, M. G. (2018) · Redox Biology · doi:10.1016/j.redox.2018.07.026 · Cited by 53
Poulos, R. C., Wong, Y. T., Ryan, R., Pang, H., & Wong, J. W. H. (2018) · PLoS Genetics · doi:10.1371/journal.pgen.1007779 · Cited by 53
Optimal control nodes in disease-perturbed networks as targets for combination therapy
Hu, Y., Chen, C., Ding, Y., Xiao, W., Wang, B., Gao, L., & Tan, K. (2019) · Nature Communications · doi:10.1038/s41467-019-10215-y · Cited by 53
Martínez-Jiménez, F., Muiños, F., López‐Arribillaga, E., López-Bigas, N., & González-Pérez, A. (2019) · Nature Cancer · doi:10.1038/s43018-019-0001-2 · Cited by 55
Galante, P. A. F., Parmigiani, R. B., Zhao, Q., Caballero, O. L., de Souza, J. E., Navarro, F. C. P., Gerber, A. L., Nicolás, M., Salim, A. C. M., Silva, A. P. M., et al. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr221 · Cited by 54
Bioinformatics and cancer target discovery
Desany, B. A., & Zhang, Z. (2004) · Drug Discovery Today · doi:10.1016/s1359-6446(04)03224-6 · Cited by 53
PERSONALIZED MEDICINE: STATE-OF-THE-ART AND PROSPECTS
Dedov, I. I., Tyul'pakov, A. I., Chekhonin, V. P., Baklaushev, V. P., Archakov, A. I., & Moshkovskii, S. A. (2012) · Annals of the Russian academy of medical sciences · doi:10.15690/vramn.v67i12.474 · Cited by 54
Jia, P., Jin, H., Meador, C. B., Xia, J., Ohashi, K., Liu, L., Pirazzoli, V., Dahlman, K. B., Politi, K. A., Michor, F., et al. (2013) · Genome Research · doi:10.1101/gr.152322.112 · Cited by 54
Control of fluxes in metabolic networksPreprint
Basler, G., Nikoloski, Z., Larhlimi, A., Barabási, A.-Ĺ., & Liu, Y.-Y. (2016) · Genome Research · doi:10.1101/gr.202648.115 · Cited by 54
Zhang, X.-F., Ou-Yang, L., & Yan, H. (2017) · Bioinformatics · doi:10.1093/bioinformatics/btx208 · Cited by 53
Reliable Single Cell Array CGH for Clinical Samples
Czyż, Z. T., Hoffmann, M., Schlimok, G., Polzer, B. M., & Klein, C. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085907 · Cited by 52
A Meta Analysis of Pancreatic Microarray Datasets Yields New Targets as Cancer Genes and Biomarkers
Goonesekere, N. C. W., Wang, X., Ludwig, L., & Guda, C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093046 · Cited by 54
Common gene signature of cancer and longevity
Budovsky, A., Tăcutu, R., Yanai, H., Abramovich, A., Wolfson, M., & Fraifeld, V. E. (2008) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2008.04.002 · Cited by 54
Ocak, S., Sos, M. L., Thomas, R. K., & Massion, P. P. (2009) · European Respiratory Journal · doi:10.1183/09031936.00042409 · Cited by 53
Kassambara, A., Hose, D., Moreaux, J., Walker, B. A., Protopopov, A. I., Reme, T. X., Pellestor, F., Pantesco, V., Jauch, A. T., Morgan, G. J., et al. (2011) · Haematologica · doi:10.3324/haematol.2011.046821 · Cited by 52
Distinctive Behaviors of Druggable Proteins in Cellular Networks
Mitsopoulos, C., Schierz, A. C., Workman, P., & Al‐Lazikani, B. (2015) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1004597 · Cited by 53
The Clonal Evolution of Metastatic Osteosarcoma as Shaped by Cisplatin Treatment
Brady, S. W., Ma, X., Bahrami, A., Satas, G., Wu, G., Newman, S., Rusch, M., Putnam, D. K., Mulder, H. L., Yergeau, D. A., et al. (2019) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-18-0620 · Cited by 52
PRODIGY: personalized prioritization of driver genes
Dinstag, G., & Ron Shamir, A. (2019) · Bioinformatics · doi:10.1093/bioinformatics/btz815 · Cited by 53
CHG: A Systematically Integrated Database of Cancer Hallmark Genes
Zhang, D., Huo, D., Xie, H., Wu, L., Zhang, J., Liu, L., Jin, Q., & Chen, X. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.00029 · Cited by 52
Bioinformatics for cancer immunology and immunotherapy
Charoentong, P., Angelova, M., Efremova, M., Gallasch, R., Hackl, H., Galon, J., & Trajanoski, Z. (2012) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-012-1354-x · Cited by 52
Amstutz, R., Wachtel, M., Troxler, H., Kleinert, P., Ebauer, M., Haneke, T., Oehler‐Jänne, C., Fabbro, D., Niggli, F. K., & Schäfer, B. W. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2447 · Cited by 52
Gevaert, O., Villalobos, V. M., Sikic, B. I., & Plevritis, S. K. (2013) · Interface Focus · doi:10.1098/rsfs.2013.0013 · Cited by 53
Massively Parallel Sequencing Approaches for Characterization of Structural Variation
Koboldt, D. C., Larson, D. E., Chen, K., Ding, L., & Wilson, R. K. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-507-7_18 · Cited by 52
Parris, T. Z., Aziz, L., Kovács, A., Hajizadeh, S., Nemes, S., Semaan, M., Chen, C. Y., Karlsson, P., & Helou, K. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-324 · Cited by 54
Vodička, P., Polívková, Z., Sytarova, S., Demová, H., Kucerová, M., Vodičková, Ľ., Vymetalkova, V. P., Naccarati, A., Šmerhovský, Z., Ambruš, M., et al. (2010) · Carcinogenesis · doi:10.1093/carcin/bgq056 · Cited by 51
Whole-exome sequencing identifies recurrent AKT1 mutations in sclerosing hemangioma of lung
Jung, S., Kim, M. S., Lee, S. H., Park, H.-C., Choi, H. J., Maeng, L.-S., Min, K. O., Kim, J., Park, T. I., Shin, O. R., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1606946113 · Cited by 51
Oral cancer databases: A comprehensive review
Sarode, G. S., Sarode, S. C., Maniyar, N., Anand, R., & Patil, S. V. (2017) · Journal of Oral Pathology and Medicine · doi:10.1111/jop.12667 · Cited by 51
Genetic epidemiology of cancer: From families to heritable genes
Hemminki, K., Rawal, R., Chen, B., & Bermejo, J. L. (2004) · International Journal of Cancer · doi:10.1002/ijc.20355 · Cited by 51
Zhao, Z., Ju, Q., Ji, J., Li, Y., & Zhao, Y. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.842833 · Cited by 52
Regional biases in mutation screening due to intratumoural heterogeneity of prostate cancer
Kim, T., Jung, S., Baek, I.-W., Lee, S., Choi, Y., Lee, J., Yeun‐Jun, C., & Lee, S. (2014) · The Journal of Pathology · doi:10.1002/path.4380 · Cited by 51
Deichmann, A., Brugman, M. H., Bartholomae, C. C., Schwarzwaelder, K., Verstegen, M. M. A., Howe, S. J., Arens, A., Ott, M., Hoelzer, D. F., Seger, R. A., et al. (2011) · Molecular Therapy · doi:10.1038/mt.2011.178 · Cited by 52
Extracting consistent knowledge from highly inconsistent cancer gene data sources
Gong, X., Wu, R., Zhang, Y., Zhao, W., Cheng, L., Gu, Y., Zhang, L., Wang, J., Zhu, J., & Guo, Z. (2010) · BMC Bioinformatics · doi:10.1186/1471-2105-11-76 · Cited by 50
Tan, I. B., Malik, S., Ramnarayanan, K., McPherson, J. R., Ho, D. L., Suzuki, Y., Ng, S. B. H., Su, Y., Lim, K. H., Koh, D., et al. (2015) · Genome biology · doi:10.1186/s13059-015-0589-1 · Cited by 50
Is there a biological cost of protein disorder? Analysis of cancer-associated mutations
Pajkos, M., Mészáros, B., Simon, I., & Dosztányi, Z. (2011) · Molecular BioSystems · doi:10.1039/c1mb05246b · Cited by 50
Zhao, J., Cheng, F., Wang, Y., Arteaga, C. L., & Zhao, Z. (2016) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m115.053199 · Cited by 50
Pucheta-Martínez, E., Saladino, G., Morando, M. A., Martinez-Torrecuadrada, J. L., Lelli, M., Sutto, L., D’Amelio, N., & Gervasio, F. L. (2016) · Scientific Reports · doi:10.1038/srep24235 · Cited by 50
Veeraraghavan, J., Ma, J., Hu, Y., & Wang, X.-S. (2016) · Breast Cancer Research and Treatment · doi:10.1007/s10549-016-3876-y · Cited by 51
Alaei-Mahabadi, B., Bhadury, J., Karlsson, J. W., Nilsson, J. A., & Larsson, E. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1606220113 · Cited by 52
Genomic Analysis Revealed New Oncogenic Signatures in TP53-Mutant Hepatocellular Carcinoma
Kancherla, V., Abdullazade, S., Matter, M. S., Lanzafame, M., Quagliata, L., Roma, G., Hoshida, Y., Terracciano, L., Ng, C. K. Y., & Piscuoglio, S. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00002 · Cited by 50
Park, S., Supek, F., & Lehner, B. (2018) · Nature Communications · doi:10.1038/s41467-018-04900-7 · Cited by 52
Mechanisms predisposing to childhood overgrowth and cancer
Rahman, N. (2005) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2005.04.007 · Cited by 50
Self-citationNonparametric Testing for DNA Copy Number Induced Differential mRNA Gene Expression
van Wieringen, W. N., & van de Wiel, M. A. (2008) · Biometrics · doi:10.1111/j.1541-0420.2008.01052.x · Cited by 50
The Molecular Genetics of Lung Cancer
Shames, D. S., Sato, M., & Minna, J. D. (2008) · Lung Cancer · doi:10.1002/9780470696330.ch4 · Cited by 50
Flood, B., Oficjalska, K., Laukens, D., Fay, J., O’Grady, A., Caiazza, F., Heetun, Z. S., Mills, K. H. G., Sheahan, K. D., Ryan, E. J., et al. (2015) · Clinical & Experimental Immunology · doi:10.1111/cei.12617 · Cited by 49
Mutational analysis of caspase 1, 4, and 5 genes in common human cancers
Soung, Y. H., Jeong, E. G., Ahn, C. H., Kim, S. S., Song, S. Y., Yoo, N. J., & Lee, S. H. (2008) · Human Pathology · doi:10.1016/j.humpath.2007.10.015 · Cited by 49
Haan, J. C., Buffart, T. E., Eijk, P. P., van de Wiel, M. A., van Wieringen, W. N., Howdle, P. D., Mulder, C. J. J., van de Velde, C. J., Quirke, P., Nagtegaal, I. D., et al. (2011) · Annals of Oncology · doi:10.1093/annonc/mdr122 · Cited by 49
Linking the kinome and phosphorylome—a comprehensive review of approaches to find kinase targets
Sopko, R., & Andrews, B. (2008) · Molecular BioSystems · doi:10.1039/b801724g · Cited by 49
BRAFV600E detection in melanoma is highly improved by COLD-PCR
Pinzani, P., Santucci, C., Mancini, I., Simi, L., Salvianti, F., Pratesi, N., Massi, D., GIORGI, V. D., Pazzagli, M., & Orlando, C. (2011) · Clinica Chimica Acta · doi:10.1016/j.cca.2011.01.014 · Cited by 49
Robust Classification Method of Tumor Subtype by Using Correlation Filters
Wang, S., Zhu, Y., Wei, J., & Huang, D.-S. (2011) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2011.135 · Cited by 49
Discovering cancer genes by integrating network and functional properties
Li, L., Zhang, K., Lee, J., Cordes, S., Davis, D. P., & Tang, Z. (2009) · BMC Medical Genomics · doi:10.1186/1755-8794-2-61 · Cited by 49
CpGIMethPred: computational model for predicting methylation status of CpG islands in human genome
Zheng, H., Wu, H., Li, J., & Jiang, S. (2013) · BMC Medical Genomics · doi:10.1186/1755-8794-6-s1-s13 · Cited by 50
The Effect of Fig Tree Latex (Ficus carica) on Stomach Cancer Line.
Hashemi, S. A., Abediankenari, S., Ghasemi, M., Azadbakht, M., Yousefzadeh, Y., & Dehpour, A. A. (2011) · Europe PMC (PubMed Central) · Cited by 49
Krøigård, A. B., Larsen, M. J., Lænkholm, A., Knoop, A. S., Jensen, J. D., Bak, M., Mollenhauer, J., Kruse, T. A., & Thomassen, M. (2015) · Oncotarget · doi:10.18632/oncotarget.3111 · Cited by 50
Core module biomarker identification with network exploration for breast cancer metastasis
Yang, R., Daigle, B. J., Petzold, L. R., & Doyle, F. J. (2012) · BMC Bioinformatics · doi:10.1186/1471-2105-13-12 · Cited by 49
Lai, D.-P., Tan, S. H., Kang, Y., Wu, J., Ooi, H.-S., Chen, J., Shen, T., Qi, Y., Zhang, X., Guo, Y., et al. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv089 · Cited by 50
ccmGDB: a database for cancer cell metabolism genes
Kim, P., Cheng, F., Zhao, J., & Zhao, Z. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv1128 · Cited by 52
Vinayanuwattikun, C., Calvez‐Kelm, F. L., Abedi‐Ardekani, B., Zaridze, D. G., Mukeria, A., Voegele, C., Vallée, M., Purnomosari, D., Forey, N., Durand, G., et al. (2016) · Scientific Reports · doi:10.1038/srep31628 · Cited by 49
Unsupervised detection of cancer driver mutations with parsimony-guided learning
Kumar, R. D., Swamidass, S. J., & Bose, R. (2016) · Nature Genetics · doi:10.1038/ng.3658 · Cited by 49
Maguire, S. L., Peck, B., Wai, P. T., Campbell, J., Barker, H. E., Gulati, A., Daley, F. M., Vyse, S., Huang, P. H., Lord, C. J., et al. (2016) · The Journal of Pathology · doi:10.1002/path.4778 · Cited by 49
Wood, H. M., Daly, C. L., Chalkley, R., Şengüven, B., Ross, L., Egan, P. A., Chengot, P., Graham, J. L., Sethi, N., Ong, T. K., et al. (2017) · Genome Medicine · doi:10.1186/s13073-017-0442-0 · Cited by 49
Next-generation sequencing-based clinical sequencing: toward precision medicine in solid tumors
Wakai, T., Prasoon, P., Hirose, Y., Shimada, Y., Ichikawa, H., & Nagahashi, M. (2018) · International Journal of Clinical Oncology · doi:10.1007/s10147-018-1375-3 · Cited by 49
Predicting synthetic lethal interactions using conserved patterns in protein interaction networks
Benstead-Hume, G., Chen, X., Hopkins, S. R., Lane, K. A., Downs, J. A., & Pearl, F. M. G. (2019) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1006888 · Cited by 50
Eskin, E. (2008) · Springer eBooks · doi:10.1007/978-3-540-78839-3_38 · Cited by 49
Wu, D., Thakore, C. U., Wescott, G. G., McCubrey, J. A., & Terrian, D. M. (2004) · Oncogene · doi:10.1038/sj.onc.1207900 · Cited by 49
Generation of mutator mutants during carcinogenesis
Venkatesan, R. N., Bielas, J. H., & Loeb, L. A. (2005) · DNA repair · doi:10.1016/j.dnarep.2005.10.012 · Cited by 49
Anelli, V., Santoriello, C., Distel, M., Köster, R. W., Ciccarelli, F. D., & Mione, M. (2009) · Zebrafish · doi:10.1089/zeb.2009.0612 · Cited by 49
Genomics and the second golden era of cancer drug development
Workman, P. (2005) · Molecular BioSystems · doi:10.1039/b501751n · Cited by 49
Diverse somatic mutation patterns and pathway alterations in human cancers
Kan, Z., Jaiswal, B. S., & Seshagiri, S. (2010) · Genome biology · doi:10.1186/gb-2010-11-s1-p37 · Cited by 49
Edmonson, M. N., Patel, A., Hedges, D. J., Wang, Z., Rampersaud, E., Kesserwan, C. A., Zhou, X., Liu, Y., Newman, S., Rusch, M., et al. (2019) · Genome Research · doi:10.1101/gr.250357.119 · Cited by 51
Woo, X. Y., Srivastava, A., Graber, J. H., Yadav, V. K., Sarsani, V., Simons, A., Beane, G., Grubb, S. C., Ananda, G., Liu, R., et al. (2019) · BMC Medical Genomics · doi:10.1186/s12920-019-0551-2 · Cited by 48
Cordycepin and kinase inhibition in cancer
Khan, M. A., & Tania, M. (2022) · Drug Discovery Today · doi:10.1016/j.drudis.2022.103481 · Cited by 48
Callahan, R., Mudunuri, U. S., Bargo, S. A., Raafat, A. M., McCurdy, D., Boulanger, C. A., Lowther, W. J., Stephens, R. M., Luke, B. T., Stewart, C., et al. (2012) · Oncotarget · doi:10.18632/oncotarget.682 · Cited by 48
Unique MicroRNA Signature and Clinical Outcome of Cancers
Yu, S., Chen, H., Yang, P., & Chen, J. J. W. (2007) · DNA and Cell Biology · doi:10.1089/dna.2006.0555 · Cited by 48
Luo, J., & Liang, S. (2014) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2014.11.004 · Cited by 48
The Progress on Genetic Analysis of Nasopharyngeal Carcinoma
Zhou, X. C., Cui, J., Macias, V., Kajdacsy‐Balla, A., Ye, H., Wang, J., & Rao, P. N. (2007) · Comparative and Functional Genomics · doi:10.1155/2007/57513 · Cited by 48
Recurrent reciprocal RNA chimera involving YPEL5 and PPP1CB in chronic lymphocytic leukemia
Velusamy, T., Palanisamy, N., Sundaram, S. K., Sahasrabuddhe, A. A., Maher, C. A., Robinson, D. R., Bahler, D. W., Cornell, T. T., Wilson, T. E., Lim, M. S., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1214326110 · Cited by 48
Suo, C., Hrydziuszko, O., Lee, D., Pramana, S., Saputra, D., Joshi, H. N., Calza, S., & Yudi Pawitan, Y. (2015) · Bioinformatics · doi:10.1093/bioinformatics/btv164 · Cited by 48
Functional and genetic analysis of the colon cancer network
Emmert‐Streib, F., Simoes, R. D. M., Glazko, G. V., McDade, S. S., Haibe‐Kains, B., Holzinger, A., Dehmer, M., & Campbell, F. C. (2014) · BMC Bioinformatics · doi:10.1186/1471-2105-15-s6-s6 · Cited by 48
Sakr, R. A., Schizas, M., Carniello, J. V. S., Ng, C. K. Y., Piscuoglio, S., Giri, D. D., de Andrade, V. P., Brot, M. D., Lim, R. S., Towers, R., et al. (2015) · Molecular Oncology · doi:10.1016/j.molonc.2015.11.001 · Cited by 49
Luo, H., Li, H., Hu, Z., Wu, H., Liu, C., Li, Y., Zhang, X., Lin, P., Hou, Q., Ding, G., et al. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.02.011 · Cited by 48
Dixit, A., Torkamani, A., Schork, N. J., & Verkhivker, G. M. (2009) · Biophysical Journal · doi:10.1016/j.bpj.2008.10.041 · Cited by 48
Wip1-deficient mice are resistant to common cancer genes
Harrison, M., Li, J., Degenhardt, Y., Hoey, T. C., & Powers, S. (2004) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.06.010 · Cited by 48
Lee, K., Famiglietti, M. L., McMahon, A., Wei, C.-H., MacArthur, J. A. L., Poux, S., Breuza, L., Bridge, A., Cunningham, F., Xenarios, I., et al. (2018) · PLOS Computational Biology · doi:10.1371/journal.pcbi.1006390 · Cited by 47
Metadata
- Authors
- Futreal, P. A., Coin, L., Marshall, M., Down, T., Hubbard, T., Wooster, R., Rahman, N., & Stratton, M. R.
- Affiliations
- Wellcome Sanger Institute (GB)
- Institute of Cancer Research (GB)
- Corresponding author
- Stratton, Michael R.
- Venue
- Nature Reviews Cancer
- Published
- 2004-03
- Volume
- 4
- Issue
- 3
- Pages
- 177-183
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- PMC
- PMC2665285
- OpenAlex
- W2102140136
- Cited by
- 3,184
- References
- 44
- Citations by year
- 2026: 13 · 2025: 51 · 2024: 71 · 2023: 134 · 2022: 109 · 2021: 143 · 2020: 166 · 2019: 204 · 2018: 237 · 2017: 190 · 2016: 191 · 2015: 228 · 2014: 201 · 2013: 208 · 2012: 164
- FWCI
- 7.35
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Research Portal (King's College London) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Keywords
- cancer genes, oncogenes, tumor suppressor, oncogenic mutations, mutation frequency, human genome, protein domains, cancer classification
- MeSH terms
- Genes, Humans, Mutation, Neoplasms, Oncogenes, Genome, Human
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review